SAT-035 Small Molecule Allosteric Agonist of Relaxin Receptor Ml290 Demonstrates Antifibrotic Properties in Liver Fibrosis
Elena M. Kaftanovskaya(Florida International University), Alexander I. Agoulnik(Florida International University), Noel Southall(National Institutes of Health), Irina U. Agoulnik(University of South Florida), Bryan Rivas(Baylor College of Medicine), Juan Marugán(National Institutes of Health), Kenneth J. Wilson(National Institutes of Health), Xin Hu(Discovery Institute), Colin E. Bishop(National Oceanography Centre), Courtney Myhr(Florida International University), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Thomas Shupe(Forest Institute), Hooi Hooi Ng(Florida International University)
Cited by 0
Related Papers
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse
|Nature Genetics|2000|351
Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene
|American Journal Of Pathology|2001|279